The statin scam is one of the worst examples of how Western medicine has sold several hundred billion dollars of a near worthless drug to millions of Americans, conning the gullible into believing that a better number on paper as the result of taking a drug somehow equates to an improvement in health. The latest nail in the statin coffin shows that women who consistently take their statins, as their doctors so happily instruct them to do, have a whopping 71 percent increased risk of developing Type 2 diabetes.

The research* is based on 161,808 postmenopausal women aged 50 to 79 years at 40 clinical centers across the United States. The researchers are from the University of Massachusetts Medical School and Harvard Medical School. In other words, this is mainstream Western medicine research.

Just as important as the study results is the bewildering press release. It tries not to alarm anyone, puts a bizarre spin on the risks and benefits of statins, and suggests that you "be sure to talk to your doctor," (the same person who has been poisoning you).

The question is, how can the “benefit” of a drug that causes a disease known to drastically increase the risk of heart disease be good for long-term heart disease prevention? The answer: It’s only “good” if you are trying to put children and healthy people (the new target market for statin idiocy) on these drugs.

Needless to say, the scholars at these prestigious think tanks could not figure out why statins cause diabetes. They still haven’t quite figured out the basics of how the human body works and what statins are doing to it.

Let me give them a few clues. Statins are anti-energy by core means of operation. Any time you reduce the energy function of a cell you reduce the ability of that cell to burn calories as fuel. This creates metabolic inefficiency and insulin resistance, with increased fatigue and eventual Type 2 diabetes.

The medical profession cannot be trusted to make correct decisions for patients when its fundamental philosophy of treating numbers on paper with drugs is more important than the person in front of them. Certainly some people are in difficult cardiovascular situations wherein the many risks of statins may be offset by a short-term benefit. Taking statins short-term would give a person time to get their act together. This type of situation, however, represents a small percentage of people on these drugs. For the majority, the serious risks of developing heart disease or Type 2 diabetes outweigh the benefits. Of course you would like better cholesterol numbers. However, you want those improved numbers because you are healthy, not because you took a sledgehammer to the core system of survival in your body. There is no shortcut to a higher quality of health.

The study is published in www.wellnessresource.com Archives of Internal Medicine